Neonatal mortality and morbidity in Down syndrome in the time of prenatal aneuploidy testing: a retrospective cohort study.

MLA

de Groot-van der Mooren, Maurike Dorothea, et al. “Neonatal Mortality and Morbidity in Down Syndrome in the Time of Prenatal Aneuploidy Testing: A Retrospective Cohort Study.” European Journal of Pediatrics, vol. 182, no. 1, Jan. 2023, pp. 319–28. EBSCOhost, https://doi.org/10.1007/s00431-022-04686-3.

APA

de Groot-van der Mooren, M. D., Scheerman, B. C., Rammeloo, L. A. J., van Wieringen, H., van Wermeskerken, A.-M., van der Plas, R., de Winter, P., Weijerman, M. E., Cornel, M. C., & van Kaam, A. H. (2023). Neonatal mortality and morbidity in Down syndrome in the time of prenatal aneuploidy testing: a retrospective cohort study. European Journal of Pediatrics, 182(1), 319–328. https://doi.org/10.1007/s00431-022-04686-3

Chicago

de Groot-van der Mooren, Maurike Dorothea, Brigitta Catharina Scheerman, Lukas Augustinus Johannes Rammeloo, Hester van Wieringen, Anne-Marie van Wermeskerken, Roos van der Plas, Peter de Winter, Michel Emile Weijerman, Martina Cornelia Cornel, and Anton Hubertus van Kaam. 2023. “Neonatal Mortality and Morbidity in Down Syndrome in the Time of Prenatal Aneuploidy Testing: A Retrospective Cohort Study.” European Journal of Pediatrics 182 (1): 319–28. doi:10.1007/s00431-022-04686-3.